EvoPAR-Prostate01: AZD5305 vs placebo in men with mCSPC - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician's Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)
Principal Investigator
Medical Oncologist
Protocol Number
IRB:
PRO00114544
NCT:
NCT06120491
Phase
Phase
III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment